- ICH GCP
- Registr klinických studií v USA
- Klinická studie NCT07627399
Effectiveness of Best Care Practices in Acute Stroke in Conventional Hospitalization (BEST CARE ICTUS_HC) (BESTCAREICTUS)
Effectiveness of Implementing Best Care Practices in the Management of Patients With Acute Stroke in Conventional Hospitalization: A Cluster-Randomized, Open, Stepped-Wedge Controlled Trial.
The goal of this clinical trial is to evaluate whether a multicomponent nurse-led intervention (BEST CARE ICTUS_HC) can reduce stroke-related complications and improve recovery in adults (18 years and older) hospitalized with an acute ischemic or hemorrhagic stroke in hospitals without specialized Stroke Units. The main questions it aims to answer are:
- Does the implementation of the program increase the early and correct detection of swallowing difficulties (dysphagia) to prevent pneumonia?
- Does the program reduce the severity of attention problems (hemineglect) and improve the patients' quality of life up to 6 months after discharge?
Researchers will compare patients receiving the BEST CARE ICTUS_HC program to patients receiving usual hospital care to see if this new approach improves patient safety and long-term functional recovery.
Participants will:
- Receive either the usual hospital care for stroke or the BEST CARE ICTUS_HC nursing program, depending on the study phase of the hospital.
- Be screened for swallowing problems using a standardized test before receiving any food or drink.
- Be cared for in an adapted environment (FLECHA Project) that uses visual signs and room organization to help with orientation and safety.
- Have their temperature, blood sugar, and blood pressure monitored under a strict specialized protocol.
- Be contacted by phone 30 days and 6 months after leaving the hospital to answer questions about their health and quality of life.
Přehled studie
Postavení
Podmínky
Intervence / Léčba
Detailní popis
#Background and Context# Significant disparities exist in acute stroke outcomes depending on the type of hospital where a patient is admitted. In the Province of Malaga, peripheral hospitals lack specialized Stroke Units, meaning patients are managed in general internal medicine or standard hospitalization wards. Evidence suggests that nurse-led protocols (such as the FeSS protocols) can reduce mortality and complications like Stroke-Associated Pneumonia (SAP), yet these are rarely standardized in non-specialized settings.
The BEST CARE ICTUS_HC model aims to bridge this gap by implementing a structured bundle of care designed to minimize preventable complications and standardize nursing excellence in these peripheral centers.
The study follows the RE-AIM framework to assess reach, effectiveness, adoption, implementation, and maintenance. In accordance with the RE-AIM framework, the study will go beyond mere clinical efficacy to analyze how the intervention's integration into routine practice modifies professional behaviors and healthcare delivery processes.
#Description of the intervention#
The intervention employs a five-pillar strategy to enhance patient safety and clinical outcomes:
- Educational Outreach: Intensive training for nursing staff in peripheral wards on stroke pathophysiology and the "compensatory care" model.
- Dysphagia and Complication Prevention: Systematic use of the Modified Swallowing Assessment (MSA) to prevent aspiration and pneumonia, replacing informal clinical judgment.
The "FLECHA" Project (Environmental Adaptation and Compensatory Care):
- Visual Signaling System: Use of standardized, color-coded pictograms and directional arrows placed at the patient's bedside. This system provides an immediate visual cue to healthcare staff and family members regarding the stroke-affected side, ensuring all interactions account for the patient's specific deficits.
- Therapeutic Spatial Reorganization: Strategic modification of the patient's immediate environment (arrangement of furniture, bedside tables, and personal items). This is designed to either encourage active visual scanning toward the neglected side (stimulation) or to safely compensate for the deficit, depending on the patient's clinical status and safety needs.
- Digital Integration of Personalized Care: Implementation of bedside QR codes that provide instant access to evidence-based nursing protocols. These digital care plans are tailored to the specific type of stroke and its lateralization, offering precise guidance on therapeutic positioning, safe mobilization techniques, and the management of invasive devices (e.g., catheters or IV lines) to prevent secondary complications.
- Physiological Control Protocols: Algorithms for the strict monitoring of temperature, blood glucose, and blood pressure to prevent secondary brain injury.
- Invasive Device Stewardship: Protocols for the early removal of catheters to reduce hospital-acquired infections and promote early mobilization.
The comparator will be the usual care provided by each unit. During the control period, hospitals will provide standard care according to their existing institutional protocols.
#Data Collection and Analysis# Data will be collected at baseline (admission), during hospitalization (daily monitoring), at discharge, and via follow-up (phone) at 30 days and 6 months. An "Intention-to-Treat" analysis will be performed using Generalized Linear Mixed Models (GLMM) to account for the clustering effect of hospitals and the time effect inherent in the stepped-wedge design.
Typ studie
Zápis (Odhadovaný)
Fáze
- Nelze použít
Kontakty a umístění
Studijní kontakt
- Jméno: JOSE MIGUEL MORALES-ASENCIO, PhD
- Telefonní číslo: +34951952833
- E-mail: jmmasen@uma.es
Studijní záloha kontaktů
- Jméno: Laura Gutierrez Rodriguez, PhD
- Telefonní číslo: +34951952880
- E-mail: laura_gr@uma.es
Studijní místa
-
-
Málaga
-
Antequera, Málaga, Španělsko, 29200
- Zatím nenabíráme
- Hospital de Antequera
-
Kontakt:
- María Socorro Zurita, Nurse
- Telefonní číslo: 951 06 16 00
- E-mail: socorro.zurita.sspa@juntadeandalucia.es
-
Marbella, Málaga, Španělsko, 29603
- Zatím nenabíráme
- Hospital Universitario Costa del Sol
-
Kontakt:
- Leticia García, Nurse
- Telefonní číslo: 951 97 66 69
- E-mail: marialeticia.garcia.d.sspa@juntadeandalucia.es
-
Ronda, Málaga, Španělsko, 29400
- Zatím nenabíráme
- Hospital de la Serranía de Ronda
-
Kontakt:
- Ángeles Gordillo, Nurse
- Telefonní číslo: 951 06 50 00
- E-mail: angeles.gordillo.sspa@juntadeandalucia.es
-
-
Velez-Maálaga
-
Málaga, Velez-Maálaga, Španělsko, 29700
- Nábor
- Hospital Comarcal de la Axarquia
-
Kontakt:
- Carmen Lupiañez Bueno, Nurse
- Telefonní číslo: +34 951 06 70 00
- E-mail: mc.lupianez.sspa@juntadeandalucia.es
-
-
Kritéria účasti
Kritéria způsobilosti
Věk způsobilý ke studiu
- Dospělý
- Starší dospělý
Přijímá zdravé dobrovolníky
Popis
Inclusion Criteria:
- Patients aged 18 years or older.
- Clinical diagnosis of acute ischemic or hemorrhagic stroke.
- Admission to conventional hospitalization units (Internal Medicine) in regional hospitals without specialized Stroke Units.
Exclusion Criteria:
- Patients admitted for a cause other than stroke who develop a stroke during their hospital stay (in-hospital stroke).
- Patients subjected to invasive neurological procedures.
- Patients undergoing invasive procedures, such as thrombectomy, who require transfer to a referral hospital and remain there for more than 48 hours.
- Patients with deterioration of the level of consciousness that prevents the performance of dysphagia testing.
- Patients that have been taken care of by Nurses and Nursing Assistants with >4 weeks of work experience in Stroke Units in the last 12 months
Studijní plán
Jak je studie koncipována?
Detaily designu
- Primární účel: Výzkum zdravotnických služeb
- Přidělení: Randomizované
- Intervenční model: Sekvenční přiřazení
- Maskování: Singl
Zbraně a zásahy
Skupina účastníků / Arm |
Intervence / Léčba |
|---|---|
|
Žádný zásah: No Intervention: usual care (control phase)
Patients receive standard clinical care according to the existing protocols of each Internal Medicine Unit before the hospital crosses over to the intervention phase.
In this phase, dysphagia screening is not standardized and relies on routine clinical assessment and medical history records.
|
|
|
Experimentální: Experimental: BEST CARE ICTUS_HC (intervention phase)
1) 3-hour training for staff on stroke care, dysphagia, and the "FLECHA" project.
2) Mandatory use of Modified Swallowing Assessment (MSA).
3) Compensatory care strategies (pictograms, spatial reorganization for hemineglect).
4) QR code-guided specific care plans.
During the implementation, in addition to the educational intervention for nurses, several complementary strategies will be employed: local leadership, analysis of barriers and facilitators, audit and feedback, provision of resources and materials, evaluation of intervention fidelity, and outreach facilitation.
|
Multicomponent nursing intervention including: 1) Specialized staff training on acute stroke care.
2) Systematic dysphagia screening using the Modified Swallowing Assessment (MSA).
3) Implementation of the "FLECHA Project", a compensatory care model that harmonizes all care delivery based on stroke laterality aimed at developing early functional rehabilitation for unilateral neglect, hemiplegia, hemiparesis, and anosognosia (strategies include use of bedside pictograms, spatial reorganization, and QR-guided specific care plans).
4) Protocols for physiological stability monitoring and early device removal.
|
Co je měření studie?
Primární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Proportion of participants with detected post-stroke dysphagia
Časové okno: Measured at hospital admission (baseline) and at hospital discharge (average of 9 days).
|
Identification of swallowing difficulties. Control Group: Dyspaghia detection based on usual care (standard clinical observation and records). Intervention Group: Dysphagia detection using the Modified Swallowing Assessment (MSA) tool. |
Measured at hospital admission (baseline) and at hospital discharge (average of 9 days).
|
|
Catherine Bergego Scale (CBS) score for Hemineglect
Časové okno: At hospital admission (baseline) and at hospital discharge (average of 9 days).
|
The CBS is a functional assessment of unilateral neglect.
It consists of 10 items related to daily living activities.
Scores range from 0 to 30, where 0 indicates no neglect and 30 indicates severe neglect.
|
At hospital admission (baseline) and at hospital discharge (average of 9 days).
|
|
Health-Related Quality of Life (HRQoL).
Časové okno: At hospital discharge, 30 days post-discharge, and 6 months post-discharge.
|
Measured using the SF-36 Health Survey in both groups.
The survey covers eight health domains, with scores ranging from 0 to 100 (higher scores indicate better health status).
|
At hospital discharge, 30 days post-discharge, and 6 months post-discharge.
|
Sekundární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Mortality
Časové okno: At hospital discharge, 30 days post-discharge, and 6 months post-discharge.
|
Incidence of death from any cause in both groups.
|
At hospital discharge, 30 days post-discharge, and 6 months post-discharge.
|
|
Mean Systolic Blood Pressure during hospitalization.
Časové okno: From hospital admission (baseline) up to hospital discharge (average of 9 days).
|
Average of systolic blood pressure readings recorded to assess physiological stability.
Unit of measurement: millimeters of mercury (mmHg).
|
From hospital admission (baseline) up to hospital discharge (average of 9 days).
|
|
Mean Body Temperature during hospitalization.
Časové okno: From hospital admission (baseline) up to hospital discharge (average of 9 days).
|
Average of body temperature readings measured daily.
Unit of measurement: degrees Celsius (°C).
|
From hospital admission (baseline) up to hospital discharge (average of 9 days).
|
|
Mean Capillary Glycemia during hospitalization.
Časové okno: From hospital admission (baseline) up to hospital discharge (average of 9 days). Unit of measurement: milligrams per deciliter (mg/dL)
|
Average of blood glucose levels.
|
From hospital admission (baseline) up to hospital discharge (average of 9 days). Unit of measurement: milligrams per deciliter (mg/dL)
|
|
Incidence of Stroke-Associated Pneumonia (SAP)
Časové okno: Through hospital discharge (average of 9 days)
|
Number of participants who develop pneumonia according to the PISCES criteria (Pneumonia in Stroke Consensus).
|
Through hospital discharge (average of 9 days)
|
|
Environmental Adaptation Compliance (Intervention Group).
Časové okno: Daily from hospital admission up to hospital discharge (average of 9 days).
|
Measured using an Intervention Checklist.
It evaluates the daily implementation of: spatial reorganization, placement of visual cues (pictograms), and accessibility of QR-coded care plans.
|
Daily from hospital admission up to hospital discharge (average of 9 days).
|
|
Duration of invasive device use
Časové okno: During hospitalization (from admission to discharge).
|
Time in days from insertion until removal of invasive devices to evaluate the impact of early removal protocols.
Specific measures include the duration of: venous access (peripheral catheters), nasogastric tubes, urinary catheters, and other catheterizations.
|
During hospitalization (from admission to discharge).
|
Další výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Sociodemographic Variables
Časové okno: At hospital admission.
|
Registration of sex, age, educational level, main caregiver availability and main caregiver's sex.
|
At hospital admission.
|
|
Clinical Characterization
Časové okno: At hospital admission.
|
Assessment of comorbidities (Charlson Comorbidity Index), type of stroke (ischemic/hemorrhagic), affected side, and prescribed treatments.
|
At hospital admission.
|
|
Length of Hospital Stay.
Časové okno: Through hospital discharge (average of 9 days).
|
Total number of days from hospital admission to discharge.
|
Through hospital discharge (average of 9 days).
|
|
All-cause hospital readmission rate at 30 days.
Časové okno: 30 days after hospital discharge.
|
Proportion of participants readmitted to the hospital for any cause within 30 days after discharge.
|
30 days after hospital discharge.
|
|
Number of rehabilitation sessions received.
Časové okno: Up to 6 months post-discharge.
|
Total count of rehabilitation sessions received by the participant.
|
Up to 6 months post-discharge.
|
|
Functional Independence measured by the Barthel Index.
Časové okno: At hospital admission (baseline) and at hospital discharge (average of 9 days)
|
Assessed using the Barthel Index (activities of daily living) and the Modified Rankin Scale (mRS) (global disability) in both groups.
|
At hospital admission (baseline) and at hospital discharge (average of 9 days)
|
|
Global disability measured by the Modified Rankin Scale (mRS).
Časové okno: At hospital admission (baseline) and at hospital discharge (average of 9 days).
|
The mRS is a scale for measuring the degree of disability or dependence in the daily activities of people who have suffered a stroke.
Scores range from 0 (no symptoms) to 6 (death).
Higher scores indicate greater disability.
|
At hospital admission (baseline) and at hospital discharge (average of 9 days).
|
Spolupracovníci a vyšetřovatelé
Sponzor
Spolupracovníci
Vyšetřovatelé
- Vrchní vyšetřovatel: JOSE MIGUEL MORALES-ASENCIO, PhD, Universidad de Málaga
Publikace a užitečné odkazy
Obecné publikace
- Pollock A, Hazelton C, Rowe FJ, Jonuscheit S, Kernohan A, Angilley J, Henderson CA, Langhorne P, Campbell P. Interventions for visual field defects in people with stroke. Cochrane Database Syst Rev. 2019 May 23;5(5):CD008388. doi: 10.1002/14651858.CD008388.pub3.
- Middleton S, Lydtin A, Comerford D, Cadilhac DA, McElduff P, Dale S, Hill K, Longworth M, Ward J, Cheung NW, D'Este C; QASCIP Working Group and Steering Committee. From QASC to QASCIP: successful Australian translational scale-up and spread of a proven intervention in acute stroke using a prospective pre-test/post-test study design. BMJ Open. 2016 May 6;6(5):e011568. doi: 10.1136/bmjopen-2016-011568.
- Langhorne P, Ramachandra S; Stroke Unit Trialists' Collaboration. Organised inpatient (stroke unit) care for stroke: network meta-analysis. Cochrane Database Syst Rev. 2020 Apr 23;4(4):CD000197. doi: 10.1002/14651858.CD000197.pub4.
- Eltringham SA, Kilner K, Gee M, Sage K, Bray BD, Pownall S, Smith CJ. Impact of Dysphagia Assessment and Management on Risk of Stroke-Associated Pneumonia: A Systematic Review. Cerebrovasc Dis. 2018;46(3-4):99-107. doi: 10.1159/000492730. Epub 2018 Sep 10.
- Burgos R, Breton I, Cereda E, Desport JC, Dziewas R, Genton L, Gomes F, Jesus P, Leischker A, Muscaritoli M, Poulia KA, Preiser JC, Van der Marck M, Wirth R, Singer P, Bischoff SC. ESPEN guideline clinical nutrition in neurology. Clin Nutr. 2018 Feb;37(1):354-396. doi: 10.1016/j.clnu.2017.09.003. Epub 2017 Sep 22.
- Norrving B, Barrick J, Davalos A, Dichgans M, Cordonnier C, Guekht A, Kutluk K, Mikulik R, Wardlaw J, Richard E, Nabavi D, Molina C, Bath PM, Stibrant Sunnerhagen K, Rudd A, Drummond A, Planas A, Caso V. Action Plan for Stroke in Europe 2018-2030. Eur Stroke J. 2018 Dec;3(4):309-336. doi: 10.1177/2396987318808719. Epub 2018 Oct 29.
- Azouvi P, Bartolomeo P, Beis JM, Perennou D, Pradat-Diehl P, Rousseaux M. A battery of tests for the quantitative assessment of unilateral neglect. Restor Neurol Neurosci. 2006;24(4-6):273-85.
- Perry L. Screening swallowing function of patients with acute stroke. Part two: Detailed evaluation of the tool used by nurses. J Clin Nurs. 2001 Jul;10(4):474-81. doi: 10.1046/j.1365-2702.2001.00502.x.
- Wolfson M, Champion H, McCoy TP, Rhodes SD, Ip EH, Blocker JN, Martin BA, Wagoner KG, O'Brien MC, Sutfin EL, Mitra A, Durant RH. Impact of a randomized campus/community trial to prevent high-risk drinking among college students. Alcohol Clin Exp Res. 2012 Oct;36(10):1767-78. doi: 10.1111/j.1530-0277.2012.01786.x. Epub 2012 Jul 23.
- Middleton S, Levi C, Ward J, Grimshaw J, Griffiths R, D'Este C, Dale S, Cheung NW, Quinn C, Evans M, Cadilhac D. Fever, hyperglycaemia and swallowing dysfunction management in acute stroke: a cluster randomised controlled trial of knowledge transfer. Implement Sci. 2009 Mar 16;4:16. doi: 10.1186/1748-5908-4-16.
- Bravata DM, Daggett VS, Woodward-Hagg H, Damush T, Plue L, Russell S, Allen G, Williams LS, Harezlak J, Chumbler NR. Comparison of two approaches to screen for dysphagia among acute ischemic stroke patients: nursing admission screening tool versus National Institutes of Health stroke scale. J Rehabil Res Dev. 2009;46(9):1127-34. doi: 10.1682/jrrd.2008.12.0169.
- Urimubenshi G, Langhorne P, Cadilhac DA, Kagwiza JN, Wu O. Association between patient outcomes and key performance indicators of stroke care quality: A systematic review and meta-analysis. Eur Stroke J. 2017 Dec;2(4):287-307. doi: 10.1177/2396987317735426. Epub 2017 Oct 5.
- Paley L, Williamson E, Bray BD, Hoffman A, James MA, Rudd AG; SSNAP Collaboration. Associations Between 30-Day Mortality, Specialist Nursing, and Daily Physician Ward Rounds in a National Stroke Registry. Stroke. 2018 Sep;49(9):2155-2162. doi: 10.1161/STROKEAHA.118.021518.
- Purvis T, Middleton S, Craig LE, Kilkenny MF, Dale S, Hill K, D'Este C, Cadilhac DA. Inclusion of a care bundle for fever, hyperglycaemia and swallow management in a National Audit for acute stroke: evidence of upscale and spread. Implement Sci. 2019 Sep 2;14(1):87. doi: 10.1186/s13012-019-0934-y.
- Middleton S, Pfeilschifter W. International translation of Fever, Sugar, Swallow Protocols: The Quality in Acute Stroke Care Europe Project. Int J Stroke. 2020 Aug;15(6):591-594. doi: 10.1177/1747493020915130. Epub 2020 Apr 16.
- Middleton S, Coughlan K, Mnatzaganian G, Low Choy N, Dale S, Jammali-Blasi A, Levi C, Grimshaw JM, Ward J, Cadilhac DA, McElduff P, Hiller JE, D'Este C. Mortality Reduction for Fever, Hyperglycemia, and Swallowing Nurse-Initiated Stroke Intervention: QASC Trial (Quality in Acute Stroke Care) Follow-Up. Stroke. 2017 May;48(5):1331-1336. doi: 10.1161/STROKEAHA.116.016038. Epub 2017 Apr 7.
- Pinero Saez S, Sanz Aznarez AC, Ruiz Garcia MV, Gonzalez Garcia MJ, Mena Sucunza L, Corcoles Jimenez MP; en nombre del Grupo de Trabajo del Programa de implantacion de buenas practicas en centros comprometidos con la excelencia en cuidados(R). Implementation of the Best practice guideline: Stroke assessment across the continuum of care in hospitalised patients. Enferm Clin (Engl Ed). 2020 May-Jun;30(3):160-167. doi: 10.1016/j.enfcli.2019.10.026. Epub 2020 Apr 14. English, Spanish.
- Hammond L, Conroy T, Murray J. Exploring oral care practices, barriers, and facilitators in an inpatient stroke unit: a thematic analysis. Disabil Rehabil. 2023 Mar;45(5):796-804. doi: 10.1080/09638288.2022.2040616. Epub 2022 Feb 21.
- Baatiema L, Otim ME, Mnatzaganian G, de-Graft Aikins A, Coombes J, Somerset S. Health professionals' views on the barriers and enablers to evidence-based practice for acute stroke care: a systematic review. Implement Sci. 2017 Jun 5;12(1):74. doi: 10.1186/s13012-017-0599-3.
- Clare CS. Role of the nurse in acute stroke care. Nurs Stand. 2020 Apr 1;35(4):75-82. doi: 10.7748/ns.2020.e11482. Epub 2020 Mar 30.
- Green TL, McNair ND, Hinkle JL, Middleton S, Miller ET, Perrin S, Power M, Southerland AM, Summers DV; American Heart Association Stroke Nursing Committee of the Council on Cardiovascular and Stroke Nursing and the Stroke Council. Care of the Patient With Acute Ischemic Stroke (Posthyperacute and Prehospital Discharge): Update to 2009 Comprehensive Nursing Care Scientific Statement: A Scientific Statement From the American Heart Association. Stroke. 2021 May;52(5):e179-e197. doi: 10.1161/STR.0000000000000357. Epub 2021 Mar 11.
- Gillen RW, Fusco-Gessick B, Harmon EY. How We Assess Spatial Neglect Matters: Prevalence of Spatial Neglect as Measured by the Catherine Bergego Scale and Impact on Rehabilitation Outcomes. Am J Phys Med Rehabil. 2021 May 1;100(5):443-449. doi: 10.1097/PHM.0000000000001710.
- Longley V, Hazelton C, Heal C, Pollock A, Woodward-Nutt K, Mitchell C, Pobric G, Vail A, Bowen A. Non-pharmacological interventions for spatial neglect or inattention following stroke and other non-progressive brain injury. Cochrane Database Syst Rev. 2021 Jul 1;7(7):CD003586. doi: 10.1002/14651858.CD003586.pub4.
- Tucker N, Stoffel JM, Hayes L, Jones GM. Blood Pressure Management Following Acute Ischemic Stroke: A Review of Primary Literature. Crit Care Nurs Q. 2020 Apr/Jun;43(2):109-121. doi: 10.1097/CNQ.0000000000000297.
- Savopoulos C, Kaiafa G, Kanellos I, Fountouki A, Theofanidis D, Hatzitolios AI. Is management of hyperglycaemia in acute phase stroke still a dilemma? J Endocrinol Invest. 2017 May;40(5):457-462. doi: 10.1007/s40618-016-0584-8. Epub 2016 Nov 21.
- Zapata-Arriaza E, Serrano-Gotarredona P, Navarro-Herrero S, Moniche F, Pardo-Galiana B, Pallisa E, Vega-Salvatierra A, Mancha F, Escudero-Martinez I, Bustamante A, Montaner J. Chest Computed Tomography Findings and Validation of Clinical Criteria of Stroke Associated Pneumonia. J Stroke. 2019 May;21(2):217-219. doi: 10.5853/jos.2018.03251. Epub 2019 Apr 17. No abstract available.
- Smith CJ, Kishore AK, Vail A, Chamorro A, Garau J, Hopkins SJ, Di Napoli M, Kalra L, Langhorne P, Montaner J, Roffe C, Rudd AG, Tyrrell PJ, van de Beek D, Woodhead M, Meisel A. Diagnosis of Stroke-Associated Pneumonia: Recommendations From the Pneumonia in Stroke Consensus Group. Stroke. 2015 Aug;46(8):2335-40. doi: 10.1161/STROKEAHA.115.009617. Epub 2015 Jun 25.
- Eltringham SA, Kilner K, Gee M, Sage K, Bray BD, Smith CJ, Pownall S. Factors Associated with Risk of Stroke-Associated Pneumonia in Patients with Dysphagia: A Systematic Review. Dysphagia. 2020 Oct;35(5):735-744. doi: 10.1007/s00455-019-10061-6. Epub 2019 Sep 6.
- Middleton S, McElduff P, Ward J, Grimshaw JM, Dale S, D'Este C, Drury P, Griffiths R, Cheung NW, Quinn C, Evans M, Cadilhac D, Levi C; QASC Trialists Group. Implementation of evidence-based treatment protocols to manage fever, hyperglycaemia, and swallowing dysfunction in acute stroke (QASC): a cluster randomised controlled trial. Lancet. 2011 Nov 12;378(9804):1699-706. doi: 10.1016/S0140-6736(11)61485-2. Epub 2011 Oct 11.
- Pudar J, Strong B, Howard VJ, Reeves MJ. Reporting of Results by Sex in Randomized Controlled Trials of Acute Stroke Therapies (2010-2020). Stroke. 2021 Nov;52(11):e702-e705. doi: 10.1161/STROKEAHA.120.034099. Epub 2021 Sep 16.
- Strong B, Pudar J, Thrift AG, Howard VJ, Hussain M, Carcel C, de Los Campos G, Reeves MJ. Sex Disparities in Enrollment in Recent Randomized Clinical Trials of Acute Stroke: A Meta-analysis. JAMA Neurol. 2021 Jun 1;78(6):666-677. doi: 10.1001/jamaneurol.2021.0873.
- Rexrode KM, Madsen TE, Yu AYX, Carcel C, Lichtman JH, Miller EC. The Impact of Sex and Gender on Stroke. Circ Res. 2022 Feb 18;130(4):512-528. doi: 10.1161/CIRCRESAHA.121.319915. Epub 2022 Feb 17.
- Alvarez-Sabin J, Quintana M, Masjuan J, Oliva-Moreno J, Mar J, Gonzalez-Rojas N, Becerra V, Torres C, Yebenes M; CONOCES Investigators Group. Economic impact of patients admitted to stroke units in Spain. Eur J Health Econ. 2017 May;18(4):449-458. doi: 10.1007/s10198-016-0799-9. Epub 2016 Apr 15.
- Ruiz Alvarez M, Aginagalde Llorente AH, Del Llano Senaris JE. [Los determinantes sociales de la salud en Espana (2010-2021): una revision exploratoria de la literatura.]. Rev Esp Salud Publica. 2022 May 12;96:e202205041. Spanish.
Termíny studijních záznamů
Hlavní termíny studia
Začátek studia (Aktuální)
Primární dokončení (Odhadovaný)
Dokončení studie (Odhadovaný)
Termíny zápisu do studia
První předloženo
První předloženo, které splnilo kritéria kontroly kvality
První zveřejněno (Aktuální)
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Aktuální)
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Naposledy ověřeno
Více informací
Termíny související s touto studií
Klíčová slova
Další relevantní podmínky MeSH
- Neurologické projevy
- Onemocnění mozku
- Onemocnění centrálního nervového systému
- Nemoci nervového systému
- Cévní onemocnění
- Kardiovaskulární choroby
- Metabolické choroby
- Infekce dýchacích cest
- Infekce
- Nemoci dýchacích cest
- Nemoci trávicího systému
- Gastrointestinální onemocnění
- Neurobehaviorální projevy
- Plicní onemocnění
- Poruchy metabolismu glukózy
- Nemoci jícnu
- Zápal plic
- Otorinolaryngologická onemocnění
- Faryngeální onemocnění
- Změny tělesné teploty
- Patologické stavy, příznaky a symptomy
- Nutriční a metabolické nemoci
- Příznaky a symptomy
- Cévní mozková příhoda
- Hemoragická mrtvice
- Mrtvice
- Poruchy deglutace
- Hyperglykémie
- Cerebrovaskulární poruchy
- Horečka
- Pneumonie, aspirace
- Poruchy vnímání
Další identifikační čísla studie
- PI25/00516
Plán pro data jednotlivých účastníků (IPD)
Plánujete sdílet data jednotlivých účastníků (IPD)?
Popis plánu IPD
Informace o lécích a zařízeních, studijní dokumenty
Studuje lékový produkt regulovaný americkým FDA
Studuje produkt zařízení regulovaný americkým úřadem FDA
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .